Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Refining the Management of Advanced Melanoma

EP. 1: Recommendations for Resectability in Melanoma

July 5th 2017

EP. 2: Adjuvant Therapy for Patients with Melanoma

July 5th 2017

EP. 3: Emerging Adjuvant and Neoadjuvant Options for Melanoma

July 5th 2017

EP. 4: Dual Targeted or Immunotherapy for BRAF-Mutant Melanoma

July 5th 2017

EP. 5: Options for NRAS-Mutant Melanoma

July 5th 2017

EP. 6: How Are You using PD-1 Testing in Melanoma?

July 5th 2017

EP. 7: Long-Term Results for Immunotherapy in Melanoma

July 5th 2017

EP. 8: New Data for Immunotherapy in Melanoma Brain Metastases

July 5th 2017

EP. 9: Oncolytic Immunotherapy in Metastatic Melanoma

July 5th 2017

EP. 10: Optimal Treatment of Metastatic Melanoma at Progression

July 5th 2017

EP. 11: Novel Combinations for Metastatic Melanoma

July 5th 2017

EP. 12: IDO Inhibitors in Metastatic Melanoma

July 5th 2017

EP. 13: Novel Targeted Therapies for Metastatic Melanoma

July 5th 2017

EP. 14: Metastatic Melanoma: Clinical Pearls From the Experts

July 5th 2017
Advertisement
Advertisement

Trending on OncLive

1

Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer

2

CAR T-Cell Engineering Produces Early Efficacy Signals in Glioblastoma

3

International Intel: A Glance at the Top Global Breast Cancer News From April-June 2026

4

Copper-Induced Cell Death Activates Immune System, May Help Overcome Immunotherapy Resistance

5

Dr Fecci on Immunotherapy Research Innovations in Glioblastoma

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us